Manufacturer:
Daiichi-Sankyo
Route of Administration:
Intravenous
Site of Care:
Outpatient
Website:
Approved Indication:
- treatment of iron deficiency anemia in adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron
- treatment of iron deficiency anemia in adult patients with non-dialysis dependent chronic kidney disease
- treatment of iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity
Conditions:
- Iron Deficiency Anemia
Therapeutic Area:
- Nephrology